Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity.

Luo S, Vacher C, Davies JE, Rubinsztein DC.

J Cell Biol. 2005 May 23;169(4):647-56.

2.

Selective degeneration in YAC mouse models of Huntington disease.

Van Raamsdonk JM, Warby SC, Hayden MR.

Brain Res Bull. 2007 Apr 30;72(2-3):124-31. Epub 2006 Nov 16. Review.

PMID:
17352936
3.

Huntington disease: new insights on the role of huntingtin cleavage.

Wellington CL, Leavitt BR, Hayden MR.

J Neural Transm Suppl. 2000;(58):1-17. Review.

PMID:
11128600
4.

Huntingtin processing in pathogenesis of Huntington disease.

Qin ZH, Gu ZL.

Acta Pharmacol Sin. 2004 Oct;25(10):1243-9. Review.

5.

Caspases in Huntington's disease.

Sanchez Mejia RO, Friedlander RM.

Neuroscientist. 2001 Dec;7(6):480-9. Review.

PMID:
11765125
7.

Huntingtin and its role in neuronal degeneration.

Li SH, Li XJ.

Neuroscientist. 2004 Oct;10(5):467-75. Review.

PMID:
15359012
8.

The selective vulnerability of nerve cells in Huntington's disease.

Sieradzan KA, Mann DM.

Neuropathol Appl Neurobiol. 2001 Feb;27(1):1-21. Review.

PMID:
11298997
9.

The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.

Arndt JR, Chaibva M, Legleiter J.

Biomol Concepts. 2015 Mar;6(1):33-46. doi: 10.1515/bmc-2015-0001. Review.

10.

Mechanisms of neurodegeneration in Huntington's disease.

Gil JM, Rego AC.

Eur J Neurosci. 2008 Jun;27(11):2803-20. doi: 10.1111/j.1460-9568.2008.06310.x. Review. Erratum in: Eur J Neurosci. 2008 Nov;28(10):2156.

PMID:
18588526
11.

Huntington's Disease.

Finkbeiner S.

Cold Spring Harb Perspect Biol. 2011 Jun 1;3(6). pii: a007476. doi: 10.1101/cshperspect.a007476. Review.

12.

Wild-type huntingtin plays a role in brain development and neuronal survival.

Reiner A, Dragatsis I, Zeitlin S, Goldowitz D.

Mol Neurobiol. 2003 Dec;28(3):259-76. Review.

PMID:
14709789
13.

[Huntington's disease: intracellular signaling pathways and neuronal death].

Humbert S, Saudou F.

J Soc Biol. 2005;199(3):247-51. Review. French.

PMID:
16471265
14.

Putting huntingtin "aggregation" in view with windows into the cellular milieu.

Hatters DM.

Curr Top Med Chem. 2012;12(22):2611-22. Review.

PMID:
23339311
15.

The P42 peptide and Peptide-based therapies for Huntington's disease.

Marelli C, Maschat F.

Orphanet J Rare Dis. 2016 Mar 17;11:24. doi: 10.1186/s13023-016-0405-3. Review.

16.

The Biology of Huntingtin.

Saudou F, Humbert S.

Neuron. 2016 Mar 2;89(5):910-26. doi: 10.1016/j.neuron.2016.02.003. Review.

17.

Autophagy in Huntington disease and huntingtin in autophagy.

Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR.

Trends Neurosci. 2015 Jan;38(1):26-35. doi: 10.1016/j.tins.2014.09.003. Epub 2014 Oct 2. Review.

PMID:
25282404
18.

Huntington's disease and Group I metabotropic glutamate receptors.

Ribeiro FM, Pires RG, Ferguson SS.

Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9. Review.

PMID:
21153060
19.

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Ehrnhoefer DE, Sutton L, Hayden MR.

Neuroscientist. 2011 Oct;17(5):475-92. doi: 10.1177/1073858410390378. Epub 2011 Feb 10. Review.

20.

Synaptic dysfunction in Huntington's disease: a new perspective.

Smith R, Brundin P, Li JY.

Cell Mol Life Sci. 2005 Sep;62(17):1901-12. Review.

PMID:
15968465

Supplemental Content

Support Center